Month: March 2021

USPSTF Updates Recommendation for LDCT Lung Cancer Screening

03/11/2021

Excerpt from the Article: The U.S. Preventive Services Task Force (USPSTF) has revised its existing lung cancer screening recommendations with two major changes – its new guidance lowers screening age and incorporates patients with a shorter smoking history. Published today in JAMA, the new recommendation now calls for patients between ages 50 and 80 who…

Read More

GT Biopharma Adds University of Wisconsin–Madison Carbone Cancer Center as Second Site in Ongoing Phase 1/2 Clinical Trial of GTB-3550 TriKE™, a Novel NK Cell Therapeutic Cancer Treatment

03/11/2021

Excerpt from the Press Release: BEVERLY HILLS, Calif., March 4, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on the development and commercialization of its disruptive, target-directed Natural Killer (NK) cell engager immunotherapy protein biologic platform technology: TriKE™ for cancer and infectious diseases, today announced the addition of a new…

Read More

Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine

03/10/2021

Excerpt from the Press Release: PRINCETON, N.J., March 4, 2021 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today publication of pre-clinical immunogenicity studies for CiVax™ (heat stable COVID-19 vaccine program) demonstrating rapid-onset,…

Read More

Massive single-cell study suggests biological roots of COVID-19 risk factors

03/09/2021

Excerpt from the Article: It’s rare for current events to inform the work of scientists as acutely as during a pandemic. In February 2020, a team of scientists from the international initiative of the Human Cell Atlas, including scientists at the Broad Institute of MIT and Harvard, sifted through a dataset on healthy human cells…

Read More

CT Colonography Identifies Pre-Malignant Polyps with Machine-Based Learning Algorithm

03/09/2021

Excerpt from the Article: Implementing a radiomics-based machine learning algorithm allows CT colonography to differentiate between benign and pre-cancerous polyps with high sensitivity and specificity. Applying a machine-based learning algorithm to images captured with CT colonography makes it possible for radiologists to differentiate between benign and pre-malignant colorectal polyps. In industrialized countries across the globe,…

Read More

Ask Us Anything in Clinical Research – The Ins and Outs of Imaging Based Clinical Trials

03/08/2021

On February 25th, we hosted our virtual networking meeting focused on the complexities of imaging based clinical trials. Thank you to everyone who participated in this exciting discussion. For those of you who wanted to join but could not, you can watch the recording below, and also register for our upcoming meetings! Register for the…

Read More

4D-Fueled AI with DCE-MRI Improves Breast Lesion Characterization

03/08/2021

Excerpt from the Article: Radiologists can classify breast lesions more accurately if they use artificial intelligence algorithms fueled by 4D data captured with dynamic contrasted-enhanced MRI (DCE-MRI), new research has found. In a study published on Feb. 24 in Radiology: Artificial Intelligence, investigators from the University of Chicago outlined their method for fusing the 4D…

Read More

Machine Learning with Contrast-Enhanced CT Can Help Identify Pulmonary Hypertension

03/08/2021

Excerpt from the Article: Using automated machine learning to calculate the right ventricle/left ventricle (RV/LV) ratio can help radiologists identify patients who have pulmonary hypertension (PH) and would benefit from being referred to a specialist. In a presentation during the 2021 European Congress of Radiology annual meeting, Pia Charters from Royal United Hospital Bath NHS…

Read More

Solving a Genetic Mystery at the Heart of the COVID-19 Pandemic

03/08/2021

Excerpt from the Article: As the COVID-19 pandemic enters its second year, scientists are still working to understand how the SARS-CoV-2 strain evolved, and how it became so much more dangerous than other coronaviruses, which humans have been living alongside for millennia. Virologists and epidemiologists worldwide have speculated for months that a protein called ORF8…

Read More